Today: 5 April 2026
Subscribe
Browse Category

Stock Market 16 October 2025

Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera Motors (NASDAQ: SEV) opened at $20.42 in its Oct. 16 direct listing, surged to $22.43, then plunged to $3.63 before stabilizing near $9, giving it a $300 million market cap. The California EV startup, which has not delivered vehicles or posted revenue, secured a $75 million equity line after listing. Aptera reported a $22.9 million loss for H1 2025 and had about $13 million in cash midyear.
16 October 2025
··
Capital One Savers Cheated Out of Billions – $425M Settlement Payout Deadline Fast Approaching

Capital One Stock Plunges 6% Amid Settlement Showdown, Big Merger & Earnings Countdown

Capital One shares fell 5.9% to $202.42 on Oct. 16, erasing a week’s gains after legal and sector concerns. The drop follows a rally to $215 the day before. The bank faces scrutiny over a $425 million settlement and reports Q3 earnings Oct. 21. Capital One completed its $35.3 billion Discover takeover in May, becoming the largest U.S. card issuer.
16 October 2025
····
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue shares hit a 52-week low of $15.46 on Oct. 16, 2025, down about 5% in one day and over 27% in the past year. The company faces new UK talcum-powder lawsuits and ongoing FDA scrutiny over Tylenol, while Q2 revenue fell 4% to $3.84 billion. Moody’s affirmed its A1 rating but cut the outlook to negative. Kenvue replaced its CEO in July and launched a strategic review, considering asset sales.
16 October 2025
·
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Skyrockets on AI Mega-Deals — Is $300 Next?

AMD shares hit record highs near $240 on Oct. 15–16, up about 80% in 2025 after major AI deals with OpenAI and Oracle. The OpenAI partnership alone added $80 billion in market value on Oct. 6. Analysts raised price targets to $300–$310. AMD reported Q2 sales of $7.69 billion and expects Q3 revenue near $8.7 billion, while continuing to chase NVIDIA’s dominant AI GPU market share.
16 October 2025
···
Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Palantir Stock Skyrockets Again – AI Boom Sparks 300% 2025 Rally (Is a Correction Coming?)

Palantir shares traded at $179.63 on Oct. 16, 2025, up about 300% year-to-date after landing a $10 billion U.S. Army contract, a £1.5 billion UK defense deal, and a new partnership with Snowflake. Q2 revenue rose 48% to $1.03 billion with GAAP profit at $327 million. Market cap stands at $426 billion. Analysts remain split, with price targets from $100 to $215 and a consensus “Hold” rating.
16 October 2025
··
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Update: New AI Chip News Sparks Bull-Bear Battle for $AAPL

Apple stock traded around $247 on Oct. 16, down nearly 1% from the previous close. Shares briefly rallied after Apple launched M5 chip-based MacBook Pro, iPad Pro, and Vision Pro Gen2 on Oct. 15, but slipped as profit-taking hit tech stocks. Wall Street targets range widely, with Wedbush at $310 and Jefferies at $205. Apple’s Q3 revenue rose 10% to $94 billion, beating estimates.
16 October 2025
·
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet (GOOGL) Stock Skyrockets on AI & Ad Revival – Could $300 Be Next?

Alphabet traded near $256 on Oct. 16, up 2% and close to record highs, putting its market value near $3 trillion. Scotiabank raised its price target to $310, citing a recovery in Google’s ad business, while BMO Capital lifted its target to $294 on AI gains. Google Cloud revenue rose 32% in Q2 to $13.6 billion. YouTube ad revenue jumped 13% to $9.8 billion, beating forecasts.
16 October 2025
··
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla Stock’s Wild Ride: Soars on Record Deliveries, Then Sags After Budget EV Reveal

Tesla reported 497,099 Q3 deliveries, beating forecasts by over 50,000 units as buyers rushed to claim expiring U.S. tax credits. TSLA shares swung sharply, surging 5% on Oct 13 before slipping 1.5% Oct 14, and traded near $430 midday Oct 16. New lower-priced Model Y and 3 trims failed to impress investors. Wall Street remains split; HSBC holds a $127 target, far below current levels.
16 October 2025
··
Kyivstar (NASDAQ: KYIV) Stock Rockets on 5G Upgrade Plans and Mastercard Tie-Up

Kyivstar (NASDAQ: KYIV) Stock Rockets on 5G Upgrade Plans and Mastercard Tie-Up

Kyivstar became the first Ukrainian company to list on Nasdaq on August 15, 2025, raising $178 million and debuting near $14 per share. After dropping to $11.25 by mid-September, the stock rebounded to $14.06 on October 16 following announcements of a $1 billion network upgrade and a Mastercard partnership. Four analysts rate KYIV a “Strong Buy” with an average price target of $17.08.
16 October 2025
··
Plug Power Stock Explodes 170% on Analyst Hype & Giant Hydrogen Deal

Plug Power (PLUG) Stock Skyrockets on Hydrogen Hype – Is PLUG a Buy or Bubble?

PLUG shares closed at $3.85 on Oct. 15, down 4.8% after doubling since early September. The company delivered a 10 MW electrolyzer to Galp Energy in Portugal on Oct. 1, part of Europe’s largest PEM project. Plug named Jose Luis Crespo as incoming CEO, prompting a 3% pre-market drop on Oct. 7. Q2 revenue rose 21% to $174 million, but the firm posted a $0.16 per-share loss.
16 October 2025
·
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Skyrockets on $100B AI Deal – Will NVDA Hit $320 Target?

Nvidia closed at $184.87 on Oct. 15, up about 30% year-to-date and far ahead of the S&P 500. The company announced a $100 billion AI deal with OpenAI and a $5 billion investment in Intel. Q2 FY2026 revenue jumped 56% to $46.7 billion, driven by data-center sales. U.S. regulators approved new Nvidia chip exports, while China increased scrutiny and opened an antitrust probe.
16 October 2025
···
Billionaire-Backed Crypto Bank Approved by Regulators – Are Tech Stocks and Crypto Ready to Soar?

Billionaire-Backed Crypto Bank Approved by Regulators – Are Tech Stocks and Crypto Ready to Soar?

The OCC granted preliminary approval for Erebor Bank, a crypto-focused startup backed by Palmer Luckey, Joe Lonsdale, and Founders Fund, marking the first new national bank charter under Comptroller Jonathan Gould. Erebor must secure FDIC insurance and meet strict capital and compliance requirements before opening. The S&P 500 rose 0.4% and Bitcoin traded near $111,000 after the news.
16 October 2025
··
Oracle Stock Surges on $300B AI Cloud Deal – Is a Trillion-Dollar Valuation Next?

Oracle Stock Surges on $300B AI Cloud Deal – Is a Trillion-Dollar Valuation Next?

Oracle shares traded near $304 on Oct. 16, 2025, up sharply year-to-date after securing major AI cloud contracts, including a reported $300 billion deal with OpenAI. Q1 FY2026 revenue rose 12% to $14.93 billion. CEO Safra Catz will step down, with Clay Magouyrk and Mike Sicilia named co-CEOs. Wall Street targets cluster in the low-to-mid $300s, though some analysts warn of high valuation risks.
16 October 2025
····
Western Alliance Bancorp Stock Plunges on First Brands Fallout — Analysts See Upside

Western Alliance Bancorp Stock Plunges on First Brands Fallout — Analysts See Upside

Western Alliance shares fell about 4% on Oct 8 and stayed down 5–6% by Oct 16 after news of exposure to bankrupt First Brands Group, which owes $10–$50 billion. A Jefferies fund held $715 million in First Brands receivables, raising fears of losses. Analysts maintain a Strong Buy consensus with a $103 average target. Q3 earnings are due Oct 21, with estimates at $2.11 EPS on $891 million revenue.
16 October 2025
·
Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

SCNX shares jumped over 30% in early trading Oct. 16 after Scienture announced Arbli, the first FDA-approved ready-to-use liquid losartan, is now available through major wholesalers. The stock hit an intraday high of $1.12 before trading near $0.71 by mid-day. Scienture recently secured a major rebate deal to drive Arbli’s adoption. Analysts remain cautious, citing weak financials and high volatility.
16 October 2025
··
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL shares jumped 13.6% to close at $85.82 on Oct. 16 after announcing a $110 million equity investment and distribution deal with Samsung C&T and Samsung Electronics. Samsung C&T will exclusively distribute GRAIL’s Galleri cancer test in South Korea, with possible expansion to Japan and Singapore. GRAL’s market cap rose to about $2.7 billion. Most analysts maintain a Hold rating despite the stock’s 321% year-to-date gain.
16 October 2025
···
1 … 1,308 1,309 1,310 1,311 1,312 … 1,371

Stock Market Today

  • Pittsburgh Housing Market Shows Signs of Heating Up Again
    April 5, 2026, 3:27 PM EDT. The Pittsburgh housing market is gaining momentum after a period of relative slowdown. Recent data indicates a rise in home sales and increased buyer interest in the region, signaling renewed confidence. Market analysts attribute this uptick to a combination of favorable mortgage rates and limited inventory, which is pushing prices higher. This trend may impact local real estate investments and financial planning for buyers and sellers alike. Monitoring these shifts is crucial for stakeholders aiming to capitalize on the evolving market dynamics.
Go toTop